Suwei Dong

Xuzhou, 221000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Rotenone Inhibited Osteosarcoma Cell Growth Through USP47-Induced Decreases in FEN1 Stability and DNA Integrity.

Rotenone Inhibited Osteosarcoma Cell Growth Through USP47-Induced Decreases in FEN1 Stability and DNA Integrity.

Journal: Drug design, development and therapy
Published: December 20, 2025

Rotenone inhibited osteosarcoma metastasis by modulating ZO-2 expression and location via the ROS/Ca2+/AMPK pathway.

Rotenone inhibited osteosarcoma metastasis by modulating ZO-2 expression and location via the ROS/Ca2+/AMPK pathway.

Journal: Redox report : communications in free radical research
Published: April 18, 2025

A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.

A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: April 23, 2023

Metformin sensitises osteosarcoma to chemotherapy via the IGF-1R/miR-610/FEN1 pathway.

Metformin sensitises osteosarcoma to chemotherapy via the IGF-1R/miR-610/FEN1 pathway.

Journal: European journal of histochemistry : EJH
Published: November 17, 2022

Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis.

Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis.

Journal: Bioengineered
Published: March 10, 2022

Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.

Predicted CD4+ T cell infiltration levels could indicate better overall survival in sarcoma patients.

Journal: The Journal of international medical research
Published: January 12, 2021

Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.

Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.

Journal: Clinical, cosmetic and investigational dermatology
Published: September 23, 2020

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma.

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin's Lymphoma.

Journal: Frontiers in oncology
Published: September 17, 2020

Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts.

Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts.

Journal: Bioengineered
Published: October 01, 2019

miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy.

miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy.

Journal: OncoTargets and therapy
Published: June 19, 2019

Increased expression of the RNA-binding motif protein 47 predicts poor prognosis in non-small-cell lung cancer.

Increased expression of the RNA-binding motif protein 47 predicts poor prognosis in non-small-cell lung cancer.

Journal: Oncology letters
Published: January 17, 2019

miR-761 inhibits human osteosarcoma progression by targeting CXCR1.

miR-761 inhibits human osteosarcoma progression by targeting CXCR1.

Journal: International journal of clinical and experimental pathology
Published: August 21, 2018
Showing 1-12 of 16

Last Updated: 09/26/2026